AzTrials
AzTrials

Pulmonary Atelectasis, PostoperativeNCT04085146

Individual Optimal Positive End-expiratory Pressure During Robot-assisted Laparoscopic Radical Prostatectomy

A study testing Individualized optimal positive end-expiratory pressure and Conventional positive end-expiratory pressure in people with Pulmonary Atelectasis, Postoperative, run by Seoul National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

During robot-assisted radical prostatectomy, pneumoperitoneum with Trendelenburg position is used. However, perioperative atelectasis and respiratory complications may occur with high incidence due to general anesthesia and carbon dioxide pneumoperitoneum. Read more about this study

Who is it for?
Ages 20 years and older, men only
Conditions the study is for
Pulmonary Atelectasis, Postoperative
What is being tested?
Individualized optimal positive end-expiratory pressure and Conventional positive end-expiratory pressure
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSouth Korea
Study dates
19 Nov 2019to 7 Aug 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing robot-assisted laparoscopic radical prostatectomy
  • Patients receiving mechanical ventilation by Aisys Care Station anesthesia ventilator
  • Patients who provided written informed consent to participate in this clinical trial

Who cannot join

  • American Society of Anesthesiologists physical status classification class 3 or more
  • Moderate or more obstructive or restrictive pulmonary disease
  • Preoperative adult respiratory distress syndrome or previous history of adult respiratory distress syndrome
  • history of heart failure, unstable angina, increased intracranial pressure
  • history of pneumothorax or presence of bullae

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Hospital

    Seoul, 03080

Other trials in South Korea

About this study

Official title: The Effect of Ventilation With Individualized Optimal Positive End Expiratory Pressure on Postoperative Atelectasis in Patients Undergoing Robot Assisted Laparoscopic Radical Prostatectomy

During robot-assisted radical prostatectomy, pneumoperitoneum with Trendelenburg position is used. However, perioperative atelectasis and respiratory complications may occur with high incidence due to general anesthesia and carbon dioxide pneumoperitoneum. Intraoperative ventilatory strategy to address these issues include intraoperative recruitment maneuver and positive end-expiratory pressure (PEEP). Recently, individualized optimal PEEP with minimal driving pressure or maximal respiratory compliance was reported to reduce respiratory complications after general anesthesia. A recent version of general anesthesia ventilator provides a stepwise procedure of determining optimal PEEP by calculating respiratory compliance. We investigated whether the application of individualized optimal PEEP could reduce the incidence of atelectasis and respiratory complications after robot-assisted laparoscopic radical prostatectomy compared to uniform PEEP.

Read the detailed description

During robot-assisted radical prostatectomy, pneumoperitoneum with Trendelenburg position is used. However, perioperative atelectasis and respiratory complications may occur with high incidence due to general anesthesia and carbon dioxide pneumoperitoneum. Intraoperative ventilatory strategy to address these issues include intraoperative recruitment maneuver and positive end-expiratory pressure (PEEP). Recently, individualized optimal PEEP with minimal driving pressure or maximal respiratory compliance was reported to reduce respiratory complications after general anesthesia. A recent version of general anesthesia ventilator provides a stepwise procedure of determining optimal PEEP by calculating respiratory compliance. We investigated whether the application of individualized optimal PEEP could reduce the incidence of atelectasis and respiratory complications after robot-assisted laparoscopic radical prostatectomy compared to uniform PEEP. We plan to determine the degree of immediate postoperative atelectasis by measuring the lung ultrasound score and compare the lung ultrasound score between groups.

Being tested
Individualized optimal positive end-expiratory pressure, Conventional positive end-expiratory pressure
Keywords
robot-assisted surgery, prostatectomy, laparoscopy, positive end-expiratory pressure, individualized, atelectasis, general anesthesia
Medical subject headings
Pulmonary Atelectasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individualized optimal positive end-expiratory pressureProcedure or surgery

    Optimal PEEP will be determined by the automated procedure of step-wised decrease in the amount of PEEP of the anesthesia ventilator Aisys Care Station (GE Healthcare, Madison, Wisconsin, USA).

  • Conventional positive end-expiratory pressureProcedure or surgery

    A same amount of PEEP of 7 centimeter hydrogen dioxide will be provided during the laparoscopic period of surgery.

Study groups in NCT04085146
Study groupRoleWhat they receive
Optimal PEEPExperimentalIndividualized optimal PEEP will be provided during the laparoscopic period of surgery. Optimal PEEP will be determined by the automated procedure of step-wised decrease in the amount of PEEP of the anesthesia ventilator Aisys Care Station (GE Healthcare, Madison, Wisconsin, USA).
Receives: Procedure: Individualized optimal positive end-expiratory pressure
Conventional PEEPActive comparatorA same amount of PEEP of 7 centimeter hydrogen dioxide will be provided during the laparoscopic period of surgery.
Receives: Procedure: Conventional positive end-expiratory pressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in lung ultrasound score

    Difference in postoperative lung ultrasound score and baseline lung ultrasound score

    Measured: 10 min after surgery

Secondary outcomes (9)
  1. Baseline lung ultrasound score

    A scoring system with a sum of the B-line score and consolidation score by lung ultrasound examination

    Measured: 10 min before the start of anesthesia induction

  2. Composite of respiratory complication

    summation of the following events: hypoxemia (pulse oximetry of 95% or less), laryngospasm, bronchospasm, pneumonia, pulmonary infiltration, aspiration pneumonia, pneumonia), pulmonary infiltration, aspiration pneumonia, development of acute respiratory distress syndrome, atelectasis, pleural effusion, pulmonary edema, pneumothorax.

    Measured: during postoperative seven days.

  3. Length of hospital stay

    Length of total hospital stay

    Measured: during the postoperative one month

  4. Postoperative Lung ultrasound score

    A scoring system with a sum of the B-line score and consolidation score by lung ultrasound examination

    Measured: 10 min after the end of anesthesia

  5. Length of intensive care unit stay

    Length of total hospital stay

    Measured: during the postoperative one month

  6. Surgical wound infection

    The rate of surgical wound infection

    Measured: during the postoperative one month

  7. Surgical wound dehiscence

    The rate of surgical wound dehiscence

    Measured: during the postoperative one month

  8. Incidence of acute kidney injury

    Incidence of postoperative acute kidney injury

    Measured: during the postoperative one month

  9. Incidence of surgical re-intervention

    Incidence of surgical re-open

    Measured: during the postoperative one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2019
  2. Study start19 Nov 2019
  3. Primary completion7 Aug 2020
  4. Study completion7 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled superiority trial with two arms of intervention.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04085146
Sponsor's protocol ID
1908-022-105
Status last verified
Oct 2021
First submitted
9 Sep 2019
Last updated
21 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Individualized optimal positive end-expiratory pressure and Conventional positive end-expiratory pressure in people with Pulmonary Atelectasis, Postoperative, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in lung ultrasound score (time frame: 10 min after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in